Episode 169 hosts Dr Christoph Martschin (Dermatologist based in Lisbon, Portugal)

Christophe has been a Galderma KOL since 2011. As a global speaker and trainer, he has a wealth of knowledge when it comes to Galderma's portfolio and research projects.

In this mini series 'The Tox Talks', we feature expert injectors who have significant experience in using botulinum toxins. These episodes explore our guests experiences using particular brands, the evolution of their injecting techniques and we get special insights into the subtle nuances of getting the best out of toxins.

In chapter 2 we focus on a newly launched brand called 'Alluzience', (Abobotulinum toxin A), a novel toxin developed by Galderma that is the world's first liquid toxin.

We explore:

- Dr Martschin's background as a Dermatologist and what his day to day practice looks like

- His role as a KOL for Galderma

- His insights into how the use of toxins has changed over the years

- The science behind the Alluzience

- Is it simply liquid abobotulinum toxin (Dysport)?

- Why does the market need a liquid toxin?

- Does it have the same characteristics as Dysport?

- What does Alluzience look like and how does it come prepared?

- What differentiates Alluzience from other brands of botulinum toxin

- How long Alluzience lasts on average

- How Alluzience is injected on label

- We find out how Christophe sees a future for clinic stocking a portfolio of different toxins to tailor treatments

- What needles and syringes he likes using and why

- What his toxin consultation consists of

- and more!

ALL IA LINKS & CONTACT INFORMATION